Rising Ophthalmic Disorders Fueling Growth In Ophthalmic Drug Market Is Supporting Development Across The Ophthalmic Drugs Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Are The Forecasted Market Size Figures For The Ophthalmic Drugs Market In 2026 And 2030?

The market size for ophthalmic drugs has shown strong growth recently. Forecasts indicate it will increase from $42.25 billion in 2025 to $45.24 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.1%. Factors contributing to its historical growth include an expanding aging population, a higher incidence of glaucoma and cataract, the proliferation of ophthalmology clinics, enhanced access to prescription eye medicines, and the broadening of hospital pharmacy networks.

The ophthalmic drugs market size is projected to experience significant expansion over the next few years. It is anticipated to grow to $61.21 billion in 2030, achieving a compound annual growth rate (CAGR) of 7.9%. The expansion during the forecast period is propelled by advancements in sustained-release ocular drug delivery, a growing understanding of eye health, the development of treatments for retinal disorders, increasing healthcare expenditure in developing economies, and the broadening adoption of over-the-counter ophthalmic products. Noteworthy trends in the forecast period encompass the rising incidence of chronic eye conditions, an escalating demand for dry eye treatments, the increased use of combination ophthalmic drugs, a transition towards preservative-free formulations, and the expansion of online pharmacies providing eye medications.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10065&type=smp

What Major Growth Factors Are Impacting The Ophthalmic Drugs Market?

The growing occurrence of ophthalmic disorders is anticipated to fuel the expansion of the ophthalmic drug market in the future. Ophthalmic disorders are defined as conditions or diseases impacting the eye and its associated structures, leading to visual impairment and other eye-related ailments. Ophthalmic drugs are medicines utilized for addressing diseases affecting the eyes or vision; consequently, the rise in ophthalmic disorder prevalence boosts demand within the ophthalmic drug market. As an illustration, in August 2023, data from the World Health Organization (WHO), a United Nations (UN) organization based in Switzerland, revealed that a minimum of 2.2 billion individuals globally experienced near or distance vision impairment in 2023. Over 1 billion of these cases were either preventable or treatable but remained unaddressed, with refractive errors and cataracts being the principal contributors. Intervention coverage stood at only 36% and 17% for these conditions, respectively. This rising prevalence of ophthalmic disorders is thus propelling the ophthalmic drug market.

What Segment Categories Are Evaluated In The Ophthalmic Drugs Market Study?

The ophthalmic drugs market covered in this report is segmented –

1) By Type: Prescription Drugs, Over-The-Counter Drugs

2) By Class: Anti-Allergy, Anti-Inflammatory, Anti-Glaucoma, Other Classes

3) By Disease: Dry Eye, Eye Allergy, Glaucoma, Eye Infection, Retinal Disorders, Uveitis, Other Diseases

4) By Dosage Form: Liquid Ophthalmic Drug Forms, Solid Ophthalmic Drug Forms, Semisolid Ophthalmic Drug Forms, Multicompartment Drug Delivery Systems

5) By Distribution Channel: Hospital Pharmacies, Drug Stores, Online Pharmacies

Subsegments:

1) By Prescription Drugs: Antiglaucoma Agents, Anti-inflammatory Drugs, Antibiotics, Antivirals, Corticosteroids, Other Prescription Drugs

2) By Over-The-Counter Drugs: Artificial Tears, Allergy Relief Medications, Redness Relievers, Ocular Vitamins And Supplements, Other OTC Drugs

What Trends Are Influencing The Ophthalmic Drugs Market Outlook?

Key companies within the ophthalmic drugs market are prioritizing the development of preservative-free medications, such as preservative-free latanoprost, to deliver effective treatment solutions. Preservative-free latanoprost denotes a specific preparation of the drug latanoprost, employed in managing conditions like glaucoma. For example, in September 2023, Thea Pharma, a US-based pharmaceutical enterprise specializing in marketing eye care products, introduced Iyuzeh (latanoprost ophthalmic solution) 0.005%. This marked the debut of a preservative-free latanoprost for primary open-angle glaucoma (POAG) and ocular hypertension (OHT) in the US. Iyuzeh, which secured FDA approval in December 2022, offers an efficacious treatment alternative for over 60 million individuals globally impacted by glaucoma.

Who Are The Prominent Players Across The Ophthalmic Drugs Market?

Major companies operating in the ophthalmic drugs market are AbbVie Inc., Alcon Inc., Bausch & Lomb Incorporated, F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Santen Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., Nicox S.A., Johnson & Johnson, Otsuka Pharmaceutical Co. Ltd., Viatris Inc., Akorn Incorporated, GlaxoSmithKline plc, Bayer AG, Senju Pharmaceutical Co. Ltd., Aerie Pharmaceuticals Inc., Kala Pharmaceuticals Inc., Aurobindo Pharma Ltd., Eyevance Pharmaceuticals, Acucela Inc., Dompe Farmaceutici S.p.A., Laboratoires Théa

Access The Complete Ophthalmic Drugs Market Report:

https://www.thebusinessresearchcompany.com/report/ophthalmic-drugs-global-market-report

Which Region Commands The Largest Share Of The Ophthalmic Drugs Market?

North America was the largest region in the ophthalmic drugs market in 2025. The regions covered in the ophthalmic drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Ophthalmic Drugs Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=10065&type=smp

Browse Through More Reports Similar to the Global Ophthalmic Drugs Market 2026, By The Business Research Company

Ophthalmic Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/ophthalmic-drugs-global-market-report

Ophthalmology Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/ophthalmology-drugs-market

Anemia And Other Blood Disorder Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/anemia-and-other-blood-disorder-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795